Molecule Name |
DB00183
|
DrugBank Groups |
Approved
|
Cluster No |
3
|
Smiles |
S(CCC(NC(=O)C(NC(=O)CCNC(=O)OC(C)(C)C)CC=2(C1(=C(C=CC=C1)NC=2)))C(=O)NC(C(=O)NC(C(=O)N)CC3(=CC=CC=C3))CC(=O)O)C
|
Download |
mol2, pdbqt
|
TPSA |
276,21
|
Non-H Atoms |
54
|
Non-C/H Atoms |
17
|
Metal-Atoms |
0
|
Electronegative Atoms |
17
|
Stereo Centers |
4
|
Rotatable Bonds |
22
|
Rings Closures |
3
|
Small Rings |
3
|
Aromatic Rings |
3
|
Aromatic Atoms |
15
|
sp3-Atoms |
19
|
Symmetric atoms |
4
|
cLogS |
-5,439
|
MW |
767,902
|
cLogP |
0,6675
|
HBA |
16
|
HBD |
8
|
Ro5 violations |
3
|
Druglikeness |
-46,834
|
DrugScore |
0,179544302338641
|
Mutagenic |
none
|
Tumorigenic |
none
|
Reproductive Effective |
none
|
Irritant |
none
|
Blood-Brain Barrier |
BBB-
|
Human Intestinal Absorption |
HIA+
|
Caco-2 Permeability |
Caco2-
|
P-glycoprotein Substrate |
Substrate
|
P-glycoprotein Inhibitor |
Inhibitor
|
P-glycoprotein Inhibitor 2 |
Non-inhibitor
|
Renal Organic Cation Transporter |
Non-inhibitor
|
Aqueous solubility |
-3,4666
|
Caco-2 Permeability 2 |
-0,1044
|
Subcellular localization |
Lysosome
|
CYP450 2C9 Substrate |
Non-substrate
|
CYP450 2D6 Substrate |
Non-substrate
|
CYP450 3A4 Substrate |
Substrate
|
CYP450 1A2 Inhibitor |
Non-inhibitor
|
CYP450 2C9 Inhibitor |
Non-inhibitor
|
CYP450 2D6 Inhibitor |
Non-inhibitor
|
CYP450 2C19 Inhibitor |
Non-inhibitor
|
CYP450 3A4 Inhibitor |
Non-inhibitor
|
CYP Inhibitory Promiscuity |
Low CYP Inhibitory Promiscuity
|
Human Ether-a-go-go-Related Gene Inhibition |
Weak inhibitor
|
Human Ether-a-go-go-Related Gene Inhibition 2 |
Inhibitor
|
AMES Toxicity |
Non AMES toxic
|
Carcinogens |
Non-carcinogens
|
Fish Toxicity |
High FHMT
|
Fish Toxicity (pLC50, mg/L) |
1,3414
|
Tetrahymena Pyriformis Toxicity |
High TPT
|
Tetrahymena Pyriformis Toxicity (pIGC50, ug/L) |
0,4249
|
Honey Bee Toxicity |
Low HBT
|
Biodegradation |
Not ready biodegradable
|
Acute Oral Toxicity |
II
|
Rat Acute Toxicity (LD50, mol/kg) |
3,8541
|
Carcinogenicity (Three-class) |
Non-required
|